Vedolizumab Shows Greater Persistence Than Tofacitinib in UC ...Middle East

Medscape - News
Vedolizumab had greater treatment persistence than tofacitinib in a retrospective study of patients with ulcerative colitis (UC) who were previously bio-naive. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Vedolizumab Shows Greater Persistence Than Tofacitinib in UC )

Apple Storegoogle play

Also on site :